Progress Toward the 90-90-90 HIV Targets in Zimbabwe and Identifying Those Left Behind
Overview
Authors
Affiliations
Objective: We present findings from the nationally representative Zimbabwe Population-based HIV Impact Assessment that characterize Zimbabwe's progress toward the Joint United Nations Programme on HIV/AIDS 90-90-90 targets.
Design: We conducted a cross-sectional household survey.
Methods: Consenting adults and children in the household were eligible to participate in Zimbabwe Population-based HIV Impact Assessment (October 2015-August 2016). Participants completed face-to-face interviews and provided blood for HIV, CD4, viral load, and syphilis testing. Viral load suppression (VLS) was defined as HIV RNA <1000 copies/mL. HIV-positive specimens were tested for the presence of selected antiretroviral drugs. Data were weighted. Analysis was restricted to HIV-positive adults aged 15-64 years.
Results: We enrolled 11,098 men and 14,033 women aged 15-64 years. HIV prevalence was 14.1%. Of those living with HIV, 76.8% (95% confidence interval [CI]: 74.9 to 78.7) were aware of their HIV status or had detectable antiretroviral levels. Of these, 88.4% (95% CI: 87.1 to 89.7) were receiving antiretroviral therapy (ART), and of these people, 85.3% (95% CI: 83.4 to 87.1) had VLS. Male sex age 15-34 years and having 1 or more sexual partners were associated with being unaware of one's HIV-positive status. Age <50 years and not taking cotrimoxazole were associated with being less likely to be being both aware and taking ART. Male sex, age <50 years, and taking cotrimoxazole were associated with being on ART but not having VLS.
Conclusions: Zimbabwe has made great strides toward epidemic control. Focusing resources on case finding, particularly among men, people aged <35 years, and sexually active individuals can help Zimbabwe attain 90-90-90 targets.
Mbita G, Mwanamsangu A, Komba A, Casalini C, Luponya M, Curran K Front Reprod Health. 2024; 6:1332236.
PMID: 38933455 PMC: 11201292. DOI: 10.3389/frph.2024.1332236.
Edun O, Okell L, Chun H, Bissek A, Ndongmo C, Shang J PLOS Glob Public Health. 2024; 4(4):e0003030.
PMID: 38573931 PMC: 10994324. DOI: 10.1371/journal.pgph.0003030.
Jopling R, Mutsvuke W, Fertig M, OCleirigh C, Mangezi W, Abas M AIDS Care. 2024; 36(sup1):168-178.
PMID: 38537178 PMC: 11283961. DOI: 10.1080/09540121.2024.2332462.
Huerga H, Ben Farhat J, Maman D, Conan N, Van Cutsem G, Omwoyo W PLOS Glob Public Health. 2023; 3(12):e0002398.
PMID: 38133999 PMC: 10745138. DOI: 10.1371/journal.pgph.0002398.
Smith-Sreen J, Bosire R, Farquhar C, Katz D, Kimani J, Masyuko S AIDS. 2023; 37(15):2421-2424.
PMID: 37965739 PMC: 10655840. DOI: 10.1097/QAD.0000000000003709.